NHGRI Aims to Make DNA Sequencing Faster, More Cost Effective
New Grants Support Quest to Develop Next Generation of Sequencing 
Technologies 

Bethesda, Md. – The National Human Genome Research Institute 
(NHGRI), part of the National Institutes of Health (NIH), today 
announced the latest round of grant awards totaling more than $13.3 
million to speed the development of innovative sequencing 
technologies that reduce the cost of DNA sequencing and expand the 
use of genomics in medical research and health care.

"There has been significant progress over the last several years to 
develop faster and more cost-effective sequencing technologies and, 
we are committed to supporting these innovative efforts to benefit 
scientific labs and medical clinics," said NHGRI Director Francis S. 
Collins, M.D., Ph.D. "These technologies will eventually 
revolutionize the way that biomedical research and the practice of 
medicine are done."

Since 1990, NHGRI has invested approximately $380 million to develop 
and improve DNA sequencing technologies. DNA sequencing costs have 
fallen more than 50-fold over the past decade, fueled in large part 
by tools, technologies and process improvements developed as part of 
the successful project to sequence the human genome. However, it 
still costs around $10 million to sequence 3 billion base pairs – 
the amount of DNA found in the genomes of humans and other mammals.

NHGRI's near-term goal is to lower the cost of sequencing a 
mammalian-sized genome to $100,000, allowing researchers to sequence 
the genomes of hundreds or even thousands of people participating in 
studies to identify genes that contribute to common, complex 
diseases. Ultimately, NHGRI's vision is to cut the cost of whole-
genome sequencing to $1,000 or less, which will enable the 
sequencing of an individual's genome during routine medical care. 
The ability to sequence an individual genome cost-effectively could 
enable health care professionals to tailor diagnosis, treatment and 
prevention to each person's unique genetic profile.

The new grants will fund nine investigators developing revolutionary 
technologies that may make it feasible to sequence a genome for 
$1,000, as well as two investigators developing "near term" 
technologies to sequence a genome for $100,000. Both approaches have 
many complementary elements that integrate biochemistry, chemistry 
and physics with engineering to enhance the whole effort to develop 
the next generation of DNA sequencing and analysis technologies. 
Since 2004, NHGRI has awarded $83 million to investigators to 
develop both "near term" and revolutionary sequencing technologies. 

"It is very important that we encourage and support the development 
of innovative sequencing technologies. Many of these new approaches 
have shown significant promise, yet far more exploration and 
development are needed if they are to be useful to the average 
researcher or physician," said Jeffery Schloss, Ph.D., NHGRI's 
program director for technology development. "We look forward to 
seeing which of these technologies fulfill their promise and achieve 
the quantum leaps that are needed to take DNA sequencing to the next 
level."

"$1,000 Genome" Grants

NHGRI's "Revolutionary Genome Sequencing Technologies" grants have 
as their goal the development of breakthrough technologies that will 
enable a human-sized genome to be sequenced for $1,000 or less. 
Grant recipients and their approximate total funding are:

John Nelson, Ph.D., General Electric Global Research, Niskayuna, 
N.Y. $900,000 (2 years) "Closed Complex Single Molecule Sequencing"

This team will use existing enzyme and dye-tagged nucleotide 
resources, the building block of DNA, in a novel way that will 
simplify the fundamental, front-end chemistry of massively parallel 
sequencing-by-synthesis. This method uses the natural catalytic 
cycle of DNA polymerase to capture just a single DNA base on an 
immobilized primer/template. A fluorescence scanner will be used to 
scan and identify hundreds of thousand of molecules at once. Then 
the cycle will be repeated. This phased award will increase if 
specific milestones are met in the initial experiments.

J. Michael Ramsey, Ph.D., University of North Carolina, Chapel Hill 
$3.8 million (4 years) "Nanoscale Fluidic Technologies for Rapidly 
Sequencing Single DNA Molecules"

A nanometer is one-billionth of a meter, much too small to be seen 
with a conventional lab microscope. Several groups are developing 
nanopores (holes about 2 nanometers in diameter) for use as DNA 
sequence transducers and propose to detect an electrical, or ionic, 
signal from individual DNA molecules. The goal of this group is to 
fabricate nanoscale channels in which single molecules of DNA will 
pass between nano-electrodes that are less than 2 nanometers apart, 
to measure an electric current that will identify individual bases.

Xiaohua Huang, Ph.D., University of California, San Diego, La Jolla 
$275,000 (1 year) "Genome Sequencing by Ligation Using Nano-Arrays 
of Single DNA Molecules"

Using an experimental method for DNA sequencing called "single 
molecule sequencing by ligation," this project aims to develop a 
method for fabricating high-density arrays of wells with sub-
micrometer dimensions for ordering single nanoparticles and DNA 
molecules. The investigator will attempt to demonstrate that more 
than 1 billion individual DNA molecules can be sequenced in massive 
parallel though a process involving cyclic sequencing by ligation, a 
process where an enzyme is used to join pieces of DNA together. This 
phased award will increase if specific milestones are met in the 
initial experiments.

Amit Meller, Ph.D., Boston University, Boston $2.2 million (3 
years) "High-Throughput DNA Sequencing Using Design Polymers and 
Nanopore Arrays" 

This group will continue to implement a novel approach previously 
funded through this program in which a nanopore is used to 
simultaneously detect electrical and fluorescent signals from many 
nanopores at one time. A novel sequencing instrument will be 
fabricated, along with additional analysis tools, with the aim of 
producing a viable, low-cost sequencing system.

Timothy D. Harris, Ph.D., Helicos Biosciences Corporation, 
Cambridge, Mass. $2 million (3 years) "High Accuracy Single Molecule 
DNA Sequencing by Synthesis"

This team of investigators has developed a fully automated 
instrument capable of sequencing single molecules of DNA on a planar 
surface. The group is now developing a high-throughput version of 
this technology for the re-sequencing of whole human genomes. The 
sequencing strategy involves obtaining short reads (about 25 DNA 
bases) from billions of strands of DNA immobilized on a surface 
inside a reagent flow cell. The research plan aims to advance this 
strategy to achieve high accuracy, re-sequencing of highly variable 
genomes and assembly of never-before sequenced genomes.

Dmitri V. Vezenov, Ph.D., Lehigh University, Bethlehem, Penn. 
$905,000 (3 years) "Force Spectroscopy Platform for Label Free 
Genome Sequencing"

This team will apply force spectroscopy, a technique used to 
understand the mechanical properties of polymer molecules or 
chemical bonds, to DNA undergoing arrested polymerization to 
initially demonstrate one-molecule-at-a-time analysis of changes in 
molecular mechanics at a resolution of a single base. Using optical, 
near-field probes, the methods of force spectroscopy can be advanced 
into techniques having massively parallel format, where millions of 
single DNA base additions can be followed at the same time. The 
identification of bases will be done exclusively on the basis of 
changes experienced by the molecule as a whole. The team aims to 
fabricate a low cost table-top setup suitable for use in a majority 
of biological, chemical and hospital laboratories.

Peiming Zhang, Ph.D., Arizona State University, Tempe, Ariz. 
$895,000 (3 years) "Fabrication of Universal DNA Nanoarrays for 
Sequencing by Hybridization"

Expanding the performance of the sequencing-by-synthesis technology, 
this group will develop a cost-effective method to fabricate 
universal DNA nanoarrays using nano-contact printing. The current 
photolithography technology can cause damage to DNA probes, which 
the group will strive to avoid by using nano-contact printing. With 
the nano-sized features, a DNA nanoarray can also improve throughput 
by offering the ability to accommodate billions of DNA molecules in 
a small area. Hybridization will be detected by atomic force 
microscopy.

Carlos H. Mastrangelo, Ph.D., Case Western Reserve University, 
Cleveland $815,000 (3 years) "Large-Scale Nanopore Arrays for DNA 
Sequencing" 

This team will aim to develop highly integrated arrays of nanopores 
that can be fabricated by lithographic methods, along with on-chip 
silicon-based electronic circuits and circuit techniques that 
amplify and isolate their various electrical signals. This group 
will also design a dipole-sensing methodology, which in principle 
can distinguish signals from each of the DNA bases. Arrays of 
nanopores will be constructed on silicon substrates using a self-
aligned compositional approach. Quadrature dipole moment detectors 
will be constructed that yield a signal independent of the rotation 
of the DNA molecule relative to the electrodes.

Jens Gundlach, Ph.D., University of Washington, Seattle $605,000 (2 
years) "Engineering MspA for Nanopore Sequencing"

The passage of single-strand DNA through a nanopore using 
electrophoresis, a method using an applied electric field to analyze 
molecular structures, has the potential to become an inexpensive, 
ultrafast DNA sequencing technique. Most current research in 
nanopore sequencing involves the protein pore, a-hemolysin; or 
artificial pores in inorganic materials. This investigator will 
explore the use of a different protein pore, Mycobacterium smegmatis 
porin A (MspA), as a new tool for nanopore sequencing.

"$100,000 Genome" Grants

NHGRI's "Near-Term Development for Genome Sequencing" grants will 
support research aimed at sequencing a human-sized genome at 100 
times lower cost than is possible today. There is strong potential 
that, in less than five years, several of these technologies will be 
at or near commercial availability. Grant recipients in the current 
cycle and their approximate total funding are:

Michael L. Metzker, Ph.D., Human Genome Sequencing Center, Baylor 
College of Medicine, Houston $500,000 (1 year) "Ultrafast SBS 
(Sequencing by Synthesis) Method for Large-Scale Human Resequencing"

This team has developed a novel type of fluorescent nucleotide that 
is modified for sequencing by synthesis. Their goal is to improve 
the chemical subunits, called reversible terminators, for use in a 
system that will ultimately be used to sequence DNA templates in 
high-density arrays, using a sensitive fluorescence detection system.

Steven Jeffrey Gordon, Ph.D., Intelligent Bio-Systems, Inc., 
Worcester, Mass. $425,000 (1 year) "High-Throughput DNA Sequencing 
by Synthesis Platform"

The main goal of this project is to develop a high-speed, massively 
parallel DNA sequencing system using unique base analogues with 
cleavable dye and reversible terminator groups and the sequencing by 
synthesis approach. This application is focused on the development 
of the subsystems required to construct high-density sample arrays 
on glass chips and to run sequencing by synthesis reactions on them 
in an automated, high-throughput fashion.

For more details about the NHGRI sequencing technology development 
grants, go to http://www.genome.gov/10000368. NHGRI also just 
announced the next round of funding under the genome sequencing 
technology program. The deadline for applying is Nov. 24, 2006, and 
information about the application process can be found at 
http://genome.gov/10000990.

Editor's Note: NHGRI Director Francis Collins will participate in a 
press conference to announce a $10 million prize offered by the X 
Prize Foundation for the creation of rapid genome sequencing 
technology. The prize is designed to stimulate competition to speed 
up the use of genome sequencing in research and medicine. The press 
conference will be held at 10 a.m. Wednesday, Oct. 4, 2006, in the 
13th floor ballroom of the National Press Club, 529 14th Street NW, 
Washington, D.C.

NHGRI is one of the 27 institutes and centers at NIH. The NHGRI 
Division of Extramural Research supports grants for research and 
training and career development at sites nationwide. Additional 
information about NHGRI can be found at www.genome.gov.

The National Institutes of Health (NIH) — The Nation's Medical 
Research Agency — includes 27 Institutes and Centers and is a 
component of the U.S. Department of Health and Human Services. It is 
the primary federal agency for conducting and supporting basic, 
clinical and translational medical research, and it investigates the 
causes, treatments, and cures for both common and rare diseases. For 
more information about NIH and its programs, visit www.nih.gov.


http://www.arizonabiotech.com/
http://tech.groups.yahoo.com/group/biotech-news/
http://www.azhttp.com/








http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
 
Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
    Individual Email | Traditional

<*> To change settings online go to:
    http://groups.yahoo.com/group/biotech-news/join
    (Yahoo! ID required)

<*> To change settings via email:
    mailto:[EMAIL PROTECTED] 
    mailto:[EMAIL PROTECTED]

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 



Reply via email to